Skip to content
Citation only via OpenAlex

Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients

Inger Hjørdis Bleskestad, Inga Strand Thorsen, Grete Jonsson, Øyvind Skadberg, Harald Bergrem, Lasse G. Gøransson

European Journal of Endocrinology · 2015 · ▲ 36 citations

Abstract

BACKGROUND: Controversies exist whether disturbances in mineral and bone disorder (MBD) normalise or persist after kidney transplantation. We assessed markers of MBD in patients with well-functioning kidney transplants to minimise confounding by reduced transplant function. METHODS: In this cross-sectional study, 40 patients aged ≥18 years who received a first kidney transplant more than 10 years ago were included. A well-functioning transplant was defined as an estimated glomerular filtration rate (eGFR) ≥45 ml/min per 1.73 m(2). RESULTS: Median time since transplantation was 18.3 years (inter quartile range (IQR) 12.2-26.2). Albumin-corrected serum calcium levels were above upper limit of normal in 15% of the transplanted patients, and serum phosphate levels below lower limit of normal in 31%. The median levels of intact parathyroid hormone (iPTH) and intact fibroblast growth factor 23 (iFGF23) were significantly higher than that in a group of healthy volunteers (11.3 pmol/l (IQR: 8.7-16.2) vs 4.4 pmol/l (IQR: 3.8-5.9), P<0.001 and 75.0 pg/ml (IQR: 53.3-108.0) vs 51.3 pg/ml (IQR: 36.3-67.6), P=0.004 respectively). There was a non-significant reduction in soluble Klotho (sKlotho) levels (605 pg/ml (IQR: 506-784) vs 692 pg/ml (IQR: 618-866)). When compared with a control group matched for eGFR, levels of iPTH were significantly higher (P<0.001), iFGF23 had a non-significant trend towards higher levels and sKlotho towards lower levels. CONCLUSIONS: In long-term kidney transplant patients with well-functioning kidney transplants, we found inappropriately high levels of iPTH and iFGF23 consistent with a state of persistent hyperparathyroidism. We speculate that the primary defect, FGF23 resistance, has evolved in the parathyroid gland before transplantation, and persists due to long half-life of the parathyroid cells.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1530/eje-14-0457
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Bleskestad, I.H., Thorsen, I.S., Jonsson, G., Skadberg, �., Bergrem, H., &amp; Gøransson, L.G. (2015). Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients. <em>European Journal of Endocrinology</em>. https://doi.org/10.1530/eje-14-0457
Vancouver
Bleskestad IH, Thorsen IS, Jonsson G, Skadberg �, Bergrem H, Gøransson LG. Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients. European Journal of Endocrinology. 2015. doi:10.1530/eje-14-0457.
BibTeX
@article{inger2015Solubl, title = {Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients}, author = {Inger Hjørdis Bleskestad and Inga Strand Thorsen and Grete Jonsson and Øyvind Skadberg and Harald Bergrem and Lasse G. Gøransson}, journal = {European Journal of Endocrinology}, year = {2015}, doi = {10.1530/eje-14-0457}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings